The calpastatin-derived calpain inhibitor CP1B reduces mRNA expression of matrix metalloproteinase-2 and-9 and invasion by leukemic THP-1 cells by Popp, O. et al.
The ubiquitously expressed calpain/calpastatin system
comprises the calpain isoforms, µ-calpain (µCp) and m-
calpain (mCp), and their endogenous inhibitor, calpas-
tatin. Calpains represent a highly conserved family of
non-lysosomal calcium-dependent cysteine proteases
that are composed of a distinct large (80 kDa) catalytic
subunit and a common small 30 kDa regulatory subunit
(see e.g. Croall and De Martino, 1991). Calpastatin con-
sists of an unique amino-terminal domain L and four tan-
dem repeats of the actual inhibitory domain (1 to 4), each
of which contains three motifs termed A, B and C (Maki
et al., 1987). Each B motif can specifically inhibit calpain
activity.
The intracellular levels of calpains and calpastatin vary
between tissues, but calpastatin is generally found at
much higher molar levels than calpains (Blomgren, 1999).
Both, proteases and inhibitor, are relatively stable with a
half-life of up to five days under normal physiological
conditions (Zhang et al., 1996). The cytosolic co-localiza-
tion of calpains and calpastatin under normal conditions
indicates that calpain must somehow escape the in-
hibitory control of calpastatin to become fully activated.
In this regard, it has been suggested that subcellular
compartmentalization of both molecule species may reg-
ulate calpain activity within cells (Lane et al., 1992; Gil-
Parrado et al., 2003a).
The wide substrate specificity of calpains underpins
their proposed roles in diverse cellular processes, includ-
ing apoptosis (e.g. Gil-Parrado et al., 2002), cell cycle
progression (e.g. Kubbutat et al., 1997), and cell motility
(e.g. Carragher et al., 1999). Knock-out mice lacking the
gene that encodes the calpain small regulatory subunit
die at around 10 days post-conception and exhibit de-
fects in vascular development, suggesting a role for cal-
pain in endothelial cell proliferation, migration or survival.
Moreover, fibroblasts derived from these knock-out em-
bryos exhibit impaired cell migration and disruption of the
actin cytoskeleton (Dourdin et al., 2001).
Migrating cells use both adhesion receptors (e.g. inte-
grins) and proteolytic enzymes to regulate their interac-
tion with and response to the ECM. Cooperation between
integrins and proteases exists at several levels: integrin
signaling induces proteases, proteases co-localize with
integrins, and proteases regulate the interface between
integrins and the intracellular cytoskeleton. Two different
mechanisms have been postulated to explain the role
played by calpains in cell migration: (i) µCp activated by
Biol. Chem., Vol. 384, pp.951 – 958, June 2003 · Copyright © by Walter de Gruyter · Berlin · New York
Oliver Popp, Michael Heidinger, Lourdes Ruiz-
Heinrich, Christian Ries, Marianne Jochum and
Shirley Gil-Parrado*
Abteilung für Klinische Chemie und Klinische
Biochemie, Chirurgische Klinik Innenstadt, Klinikum der
LMU München, Nussbaumstr. 20, D-80336 München,
Germany
*Corresponding author
The ubiquitous proteases µ- and m-calpain are 
Ca2 +-dependent cysteine endopeptidases. Besides
involvement in a variety of physio(patho)logical pro-
cesses, recent studies suggest a pivotal role of cal-
pains in differentiation of hematopoietic cells and tu-
mor cell invasion. However, the precise actions of
calpains and their endogenous inhibitor, calpastatin,
in these processes are only partially understood.
Here we have studied the role of the calpain/calpa-
statin system in the invasion of leukemic cells under
basal and differentiation-stimulating conditions. To
further differentiate the human leukaemic cell line
THP-1 (monocytic), the cells were treated for 24 hours
with the differentiation-stimulating reagents phorbol
12-myristate 13-acetate (PMA) and dimethyl sulfox-
ide (DMSO). Macrophage- and granulocyte-like dif-
ferentiation was confirmed by induction of vimentin
expression as well as by microscopic and fluores-
cence-assisted cytometric analysis. Extracellular
matrix (ECM) invasion of both the basal and differen-
tiation-stimulated cells in a Matrigel assay was inhib-
ited by pre-incubation of the cells with the specific
calpain inhibitor CP1B for 24 hours. Inhibition of inva-
siveness correlated with decreased mRNA expres-
sion and secretion of the matrix metalloproteinases
MMP-2 and MMP-9. In contrast, addition of CP1B
only during the invasion process did neither influence
transmigration nor MMP release. This is the first re-
port showing that the calpain/calpastatin system me-
diates MMP-mRNA expression of the leukemic THP-1
cells and as a consequence their invasiveness.
Key words: Calpastatin /Differentiation / Inhibitor /
Protease /Tumor.
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integrins degrades members of the Rho family of GTP
ases, such as Rac and RhoA, which are themselves acti-
vated by β3-integrins to mediate focal cell adhesion
(Bialkowska et al., 2000), and (ii) epidermal growth factor
receptor signaling via the ERK/MAPK pathway activates
mCp, which induces the proteolytic abrogation of cell ad-
hesion (Glading et al., 2000).
Besides calpains other protease systems, such as ma-
trix metalloproteinases (MMPs) and the urokinase/uroki-
nase receptor (uPAR)/plasmin system, are intimately
connected to the integrins and ECM during the process
of cell migration. Regulation of MMP expression due to
cell-ECM contacts has been reported, and in particular
diverse integrins were shown to mediate the expression
of the primary matrix degrading proteinases, MMP-9 and
MMP-2 (Huhtala et al., 1995). Tumor cell migration
through the ECM requires the cooperation of cell adhe-
sion and local proteolysis of ECM components such 
as basement membranes, collagens, fibronectin and
laminin. MMPs are responsible for ECM breakdown un-
der both normal and pathological conditions (reviewed in
Itoh and Nagase, 2002). Secretion of MMPs, predomi-
nantly of MMP-2 and MMP-9, has been demonstrated in
various cellular systems to correlate with the capacity of
tumor cells for invasion and metastasis (Stetler-Steven-
son et al., 1993).
Although MMPs and the uPA system seem to play the
major role in tumor development and invasion, recent re-
sults from various studies also point to the relevance of
calpain within these processes. For instance, increased
calpain activity has been detected in breast cancer tis-
sues (Shiba et al., 1996), and in human renal cell carcino-
mas significantly higher levels of µCp expression were
found in tumors metastazing to peripheral lymph nodes
compared to tumors that have not metastasized (Braun
et al., 1999). Interestingly, calpain-mediated proteolysis of
the tumor suppressor protein, neurofibromatosis type 2, 
is associated with the development of schwannomas and
meningiomas (Kimura et al., 2000). Finally, elevated cal-
pain activity in chronic lymphocytic leukemic cells
(Witkowski et al., 2002) and involvement of calpains in
differentiation of leukemic cells have been reported as
well (Deshpande et al., 1995). However, it is not clear how
the calpain/calpastatin system is regulated in leukemic
cells at diverse stages of differentiation.
In view of the fact that calpain is required for MMP-2
and uPA-expression in SV40 large T-antigen-immortal-
ized cells (Postovit et al., 2002), and that the gelatinases
MMP-2 and MMP-9 are highly expressed in leukemic
cells (Ries et al., 1999), we focused on a potential inter-
action between the calpain/calpastatin system and these
two gelatinases during leukemic cell invasion. Further-
more, we addressed whether this interaction depends on
the cellular differentiation stages, i.e. monocytic, macro-
phage- or granulocyte-like stages.
To address these issues we cultivated the human
monocytic cell line THP-1 under serum-free conditions in
RPMI 1640 medium supplemented with 1% Nutridoma
(Roche, Basel). This cell line can be further stimulated to
differentiate into a macrophage- or granulocyte-like
stage, respectively (Auwerx, 1991; Drexler et al., 1995).
For induction of macrophage- (Hubermann and Calla-
ham, 1979) or granulocyte-like (Collins et al., 1978) differ-
entiation cells were treated for 24 or 48 hours with either
PMA (80 nM) or DMSO (1.28 µM), respectively. Compared
to starting conditions neither PMA nor DMSO were cyto-
toxic throughout a 48 hour study period to a significant
extent as assessed by co-staining with annexin V fluo-
rescein isothiocyanate (FITC) and propidium iodide (PI)
(Figure 1). In further experiments, leukemic cells were
stimulated to differentiate by pre-incubation with the indi-
cated concentrations of PMA- or DMSO for 24 h. PMA-
stimulated macrophage differentiation of THP-1 was
confirmed by induction of vimentin expression (Cabanas
et al., 1990; Figure 2B), as well as by microscopic (Fig-
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Fig. 1 Effect of PMA and DMSO on the Viability of Leukemic
THP-1 Cells.
Cell viability was assessed by flow cytometry, simultaneously
monitoring FITC-labeled annexin V binding and propidium iodide
(PI) uptake. THP-1 (DSMZ # ACC 16) cells (5×106) were treated
with PMA or DMSO to induce macrophage- or granulocyte-like
differentiation, respectively. Routine cell culture was performed
in RPMI 1640 medium (PAA, Linz, Austria) supplemented with
10% fetal calf serum (PAA) and 1% glutamine solution (Gibco-
BRL, Paisley, UK) at 37°C in a humidified 5% CO2 incubator. Cell
differentiation in serum-free medium supplemented with 1% Nu-
tridoma-SP (Roche, Mannheim, Germany) was stimulated by ad-
dition of 80 nM PMA (Sigma, St. Louis, USA) or 1.28 µM DMSO
(Fluka, Buchs, Switzerland) for 24 or 48 hours. All cell culture ma-
terials were purchased from NUNC, (Rochester, USA). After
treatment with PMA or DMSO, cells were resuspended in 2 ml of
annexin V binding buffer, and finally analyzed with FITC-annexin
V and PI (9:1) for 5 min at room temperature according to the
manufacture´s protocol (Roche). Fluorescence of 20 000 cells
was measured with a flow cytometer (XL-MCL; Coulter, Miami,
USA) through 525/20 bandpass filter to monitor annexin-fluores-
cence-phosphatidylserine binding and through a 620/15 filter to
monitor PI uptake. Cell viability (%) represents the percentage of
cells negative for FITC-annexin V binding and PI related to the to-
tal amount of cells. Note that DMSO and PMA do not induce sig-
nificant cell death during the 48 h incubation period. The values
are given as mean of three independent experiments.
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Fig. 2 Characterization of Macrophage-Like Differentiation of Leukemic THP-1 Cells. 
(A) Adherent becoming cells after PMA-treatment (see legend to Figure 1) for 24 h (phase contrast). The bar in the panel is equivalent to
30 µm. (B) Induction of vimentin expression as marker for macrophage-like differentiation. Adherent cells were trypsinized and washed
with pre-chilled PBS. For preparation of cytosolic extract, cells were resuspended in freshly prepared lysis buffer (10 mM HEPES, 10 mM
KCl, 1.5 mM MgCl2, 1 mM EDTA, pH 7.5), supplemented with 1% protease inhibitor cocktail set III (Calbiochem, San Diego, USA), and
lysed by four cycles of freezing and thawing. Total protein concentration was determined by the BCA method (Smith et al., 1985). Cy-
tosolic extracts were then mixed with sample buffer, heated for 2 – 5 minutes at 95°C and electrophoretically resolved on SDS-Tris
glycine polyacrylamide (10%) gels. Finally, samples were transferred to nitrocellulose membranes (Schleicher & Schuell, Dassel, Ger-
many) and probed with a monoclonal anti-human vimentin antibody (Novocastra, Newcastle, UK). Antibody/protein complexes were
detected with anti-mouse horse radish peroxidase (HRP)-linked IgG (New England Biolabs, Beverly,USA), using the SuperSignal®
chemiluminescence detection kit (Pierce, Rockford, USA). (C) Increase of the macrophage-specific CD69 [arrow, anti-CD69 phycoery-
thrin (PE); Caltag, Burlingame, USA] and (D), fading of hematopoietic progenitor marker CD34 (arrow, anti-CD34-FITC; Caltag) were ob-
served using fluorescence-assisted analysis. For this, PMA-stimulated cells were washed and incubated for 30 minutes on ice with the
appropriate antibody and subsequently analyzed using a flow cytometer (XL-MCL, Coulter). Blue, isotype control; red, untreated cells;
green, treated cells. Results are representative of three replicas.
Fig. 3 Characterization of Granulocyte-Like Differentiation of Leukemic THP-1 Cells.
(A) Granulocyte-like differentiation of THP-1 cells after treatment with DMSO for 24 h (see legend to Figure 1) shown by Wright-Giem-
sa-staining (arrow). The bar in the panel is equivalent to 30 µm. (B) Reduction of hematopoietic progenitor CD34 was detected by fluo-
rescence-assisted analysis (arrow, anti-CD34-FITC; Caltag). Blue, isotype control; red, untreated cells; green, treated cells. Results are
representative of three replicas.
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ure 2A) and fluorescence-assisted cytometric analysis
(Figure 2C-D). We detected an increase in the expression
level of the macrophage-specific CD69 (Figure 2C), a dif-
ferentiation marker of cells becoming adherent, with a si-
multaneous reduction of the hematopoietic progenitor
marker CD34 (Figure 2D). In addition, cells incubated
with DMSO were stained with Wright-Giemsa-reagent
(Figure 3A), exhibiting granulocyte subcellular compo-
nents concomitantly with the reduction of both the
hematopoietic progenitor marker CD34 (Figure 3B) and
of α-naphthyl acetate esterase activity (data not shown).
Summarizing the native (80 kDa) and the autolytical
product (76 kDa) of the large subunit, calpain protein lev-
els in the cytosolic extracts as determined by Western
blotting were nearly unchanged after stimulation of the
leukemic cell lines with PMA or DMSO (Figure 4A). Fur-
ther, we did not detect significant differences in hydroly-
sis of the fluorogenic peptide substrate Suc-LY-amc in
cytosolic extracts (Figure 4B, bars 1). This activity was re-
duced by CP1B (Figure 4B, bars 2), a highly specific cal-
pain inhibitor (Ki values: 0.2 nM for calpain, 6 µM for
cathepsin L, ≥500 µM for cathepsin B and caspase 3) de-
rived from the B motif of calpastatin (Gil-Parrado et al.,
2003b), indicating that a significant part of the Suc-LY-
amc hydrolytic activity resulted from calpain. In addition,
cytosolic extracts of cells pre-incubated for 24 h with
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Fig. 4 Calpain Expression and Activity in Cytosolic Extracts of THP-1 Cells Cultivated under Basal and Differentiation-Stimulating
Conditions.
(A) Western blot analysis of cytosolic extracts (see also legend to Figure 1) for calpain expression in THP-1 cells indicate no significant
differences in the expression of the calpain large subunit (80 kDa, 76 kDa). Cytosolic extracts were electrophoretically separated and
transferred to a nitrocellulose membrane as described in Figure 2. The samples were probed against a monoclonal anti-human calpain
antibody (RDI, Flanders, USA), recognizing the native (80 kDa) and the autolytic product (76 kDa) of the calpain large subunit as well.
(B) Calpain activity in cytosolic extracts (n=3) from cells either pre-incubated or not with CP1B (50 µM, CP1B STI) for 24 h revealed no
significant differences between unstimulated and differentiation-stimulated cells (bars 1) as measured by hydrolysis of the fluorogenic
peptide substrate Suc-LY-amc. Most of the Suc-LY-amc hydrolysis could be inhibited by pre-incubation with the specific calpain in-
hibitor CP1B (10 nM, Sigma; bars 2), indicating that calpain is mainly responsible for this activity. Further, pre-incubation of cells with
CP1B (50 µM) for 24 h markedly reduced the calpain activity since non significantly differences were detected between CP1B-pre-in-
cubated cells before (bars 3) and after addition (bars 4) of CP1B (10 nM) during the activity assay. As positive control, purified human
µCp (5 nM) isolated from erythrocytes was used. The activity assay contained 100 mM DTT, 20 mM CaCl2, 25 mM Suc-LY-amc and ap-
propriate amounts of sample (5 µg cytosolic extracts). All experiments were performed in triplicate. 
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Fig. 5 Reduction of ECM Invasion and Secretion of MMP-2 and MMP-9 by Pre-Incubation of THP-1 Cells with the Calpain Inhibitor
CP1B.
(A) The cell invasion assay was performed as previously described (Zang et al., 2000). THP-1 cells either untreated or stimulated to dif-
ferentiate with PMA and DMSO, were pre-incubated or not with CP1B (50 µM) for 24 h (CP1B STI). The cells (1×105) were washed and then
plated on a 6 µm pore transwell insert (Costar, Cambridge, USA) coated with 20 µg Matrigel (mouse ECM; Becton Dickinson, Franklin
Lakes, USA). The upper and lower compartments of the transwell chamber contained RPMI medium supplemented with 1% Nutridoma
in the presence or absence of CP1B (50 µM) (CP1B INV). The lower compartment contained 1% fetal calf serum to induce chemotactic
cell migration. After 24 h of incubation at 37°C and 5% CO2, cells that had transmigrated either into the lower compartment or remained
at the filter were quantified using a Neubauer chamber (cell number) or a fluorescence reader (F635nm; Tecan, Maennedorf, Switzerland),
respectively. Remarkably, cells cultivated in Nutridoma or treated with DMSO were only found in the lower compartment, in contrast to
cells treated with PMA that remained at the filter after transmigration. Briefly, transmigrated cells that remained at the filter were rinsed in
phosphate-buffered saline (PBS) and immersed for 10 minutes in 3.7% freshly prepared formaldehyde. Thereafter, these cells were per-
meabilized for 2 minutes with 0.2% Triton X-100. Finally, cells were stained with 20 µg/ml PI (DNA-label) for 30 minutes before fluores-
cence readings. The relative migration (invasion index) was calculated by setting the number of migrated cells without CP1B addition in
each treatment [Nutridoma (monocytic): 2354±352 cells + 0 F635nm; PMA-treated cells (macrophage-like): 0 cells + 368±50 F635nm; DMSO-
treated cells (granulocyte-like): 7020±1404 cells + 0 F635nm] as 100%. Note that pre-incubation of the cells with CP1B for 24 h significant-
ly reduced the ECM invasiveness of THP-1 cells. Cell viability as assessed by the trypan blue-exclusion dye test (Sigma) amounted to
96±5%. The values are given as mean of four independent experiments. (B) Analysis of the secreted proenzyme forms of MMP-2 and
MMP-9 was performed by zymography using minigels containing 0.1% gelatin according to the manufacture´s protocol (Invitrogen,
Carlsbad, USA). Aliquots of conditioned media (8 µg total protein) collected from the upper compartment of the invasion chamber were
subjected to zymography. Remarkably, secretion of MMP-9 (and to a lesser degree of MMP-2) detected by gel scanning of the lysis area
(Jaroslava et al., 1999) was significantly diminished in cells that had been pre-incubated with CP1B for 24 h. In contrast, addition of CP1B
only during the invasion process did not reduce transmigration capacity (A) nor MMP release (B). As control for MMP-2 and MMP-9 re-
lease, conditioned medium from HT 1080 cells was used (M) (Stanton et al., 1998).
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cell-permeable CP1B were also analyzed for Suc-LY-amc
hydrolysis. This treatment reduced significantly the Suc-
LY-amc hydrolytic activity (Figure 4B, bars 3), again sug-
gesting the inhibition of calpain activity throughout the in-
cubation period. Finally, and consistent with these
results, exogenous addition of CP1B to the latter extracts
during the activity assay did only slightly further diminish
Suc-LY-amc hydrolytic activity (Figure 4B, bars 4). Thus,
these results conclusively confirm that pre-incubation
with CP1B for 24 h reduces significantly calpastatin-in-
hibitable Suc-LY-amc hydrolysis, and therefore, calpain
activity.
Since several calpain substrates are components of
focal adhesion complexes whose remodeling is required
for cellular migration, we studied the influence of calpain
activity on the invasiveness of THP-1 cells using a Ma-
trigel-based (ECM) transwell invasion assay in the pres-
ence or absence of CP1B. Before applying the cells in the
invasion assay, basal and differentiation-stimulating cul-
tivation of THP-1 cells was performed in the presence
and absence of the calpain inhibitor as outlined above.
The invasion index was defined as relative migration by
setting the number of untreated cells that had migrated to
the lower compartment as 100%. Remarkably, the inva-
sion index of both differentiation-stimulated and untreat-
ed cells was significantly reduced after pre-incubation
with CP1B for 24 h (Figure 5A).
To evaluate a possible interaction between the cal-
pain/calpastatin system and MMPs, culture supernatants
of THP-1 cells either pre-incubated or not with CP1B dur-
ing (i) differentiation, (ii) invasion or (iii) differentiation and
invasion were analyzed for secreted MMP-2 and MMP-9
using gelatin-incorporated SDS polyacrylamide gels.
This zymographic analysis of THP-1 culture supernatants
showed a constitutive secretion of MMP-2 and MMP-9 in
their proenzyme form with apparent molecular masses of
72 and 94 kDa, respectively. An additional band at
180 kDa appears to represent the MMP-9 dimer as ob-
served under non-reducing condition of zymography
gels (Olson et al., 2000) (Figure 5B). Stimulation of the
cells with PMA or DMSO significantly augmented the re-
lease of MMP-9 but not of MMP-2, which is in accord
with previous findings in these cells (Van Ranst et al.,
1991). Treatment of the cells for 24 hours with CP1B dur-
ing cultivation under basal conditions as well as during
stimulation with PMA or DMSO induced a prominent
down-regulation of MMP-9 and to a lesser degree also of
MMP-2 secretion (Figure 5B).
To rule out that MMP-2 and -9 secretion as well as re-
duced invasiveness were results of PMA- or DMSO-in-
duced cell death, cell viability was monitored by cell
staining with trypan blue after transmigration, exhibiting
no relevant cell death (data not shown). On the other
hand, there is ample evidence suggesting that CP1B is
not cytotoxic, e.g. CP1B (50 µM) prevents ionomycin-in-
duced apoptosis of LCLC 103H and COS 7 cells (Gil-Par-
rado et al., 2002). Further indirect evidence for the non-
cytotoxicity of CP1B is provided by the observation that
addition of CP1B during the transmigration assay (Fig-
ure 5, CP1B INV) for 24 hours did not affect invasion (Fig-
ure 5, bars 3) or MMP-expression (Figure 5, lanes 3).
Since addition of CP1B only during the invasion had no
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Fig. 6 Reduction of MMP-2 and MMP-9 mRNA Expression by Pre-Incubation of THP-1 Cells with CP1B.
THP-1 cells, either unstimulated (Nutridoma) or treated with PMA or DMSO, were cultivated for 24 h without or with CP1B (50 µM).
Thereafter, total RNA was isolated using the RNeasy® Kit (Qiagen, Hilden, Germany) according to the manufacturer´s protocol. The iso-
lated RNA was reverse transcribed in cDNA with the First Strand cDNA Synthesis Kit (Roche). Primers for RT-PCR were purchased from
Search LC (Heidelberg, Germany). Quantification of mRNA levels was carried out by automated real-time RT-PCR (LightCycler™,
Roche). mRNA levels of MMP-2 and MMP-9 were normalized to that of the house-keeping gene GAPDH. The relative mRNA expres-
sion was calculated by setting the normalized mRNA levels of cells (unstimulated and stimulated with PMA or DMSO) without inhibitor
treatment as 100%. Note that reduced mRNA expression of MMP-2 and especially of MMP-9 correlates with the diminished secretion
of these proteinases during the ECM invasion by THP-1 cells (see Figure 5B).
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effect on the release of these two MMPs, we hypothe-
sized that the calpain/calpastatin system might regulate
primarily the expression of MMPs rather than their secre-
tion. Therefore, we quantified the mRNA expression lev-
els of MMP-2 and MMP-9 from unstimulated and differ-
entiation-stimulated cells cultivated for 24 h in the
presence or absence of CP1B (Figure 6). Indeed, a signif-
icant reduction of the gelatinase mRNA levels from cells
pre-incubated with CP1B was found using real-time
quantitative PCR. Noteworthy, the CP1B-mediated de-
crease was observed in unstimulated leukemic cells as
well as in their macrophage- and granulocyte-like stages.
The stronger reduction of MMP-9 mRNA levels com-
pared to those of MMP-2 correlated with both fewer
proenzyme release of MMP-9 than of MMP-2 as shown
by zymography (Figure 5B) and reduced invasiveness
(Figure 5A). Since invasion requires extracellularly active
proteases for breakdown of the ECM, one can expect
that the amount of released proMMPs correlates with
their activation during the invasion process (Nagase and
Woessner, 1999).
Although calpains are localized mostly intracellularly,
several reports indicated the presence of extracellular
mCp on collagen fibrils (Badalamante et al., 1987), in en-
doneural collagen fibrils and the basal laminae of
Schwann cells (Mata et al., 1991), around the cartilage-
nous matrix (Shimizu et al., 1991), and in extracellular fi-
brous tissues, calluses and perivascular areas (Naka-
gawa et al., 1994). To evaluate whether extracellular
calpain might have been involved in the invasion process,
we analyzed the culture supernatants of the upper com-
partment of the invasion chamber for the presence of se-
creted calpain. However, using an ELISA that had been
optimized for calpain detection in conditioned medium,
we could not detect any increase in the calpain release
during transmigration by these leukemic cells independ-
ently on the differentiation stage (data not shown). Never-
theless, we would like to emphasize that our results do
not exclude the possibility that activated calpain bound
to the cell membrane (Gil-Parrado et al., 2003a) of mi-
grating cells might have contributed to ECM degradation
during invasion.
In summary, we have demonstrated that the specific
calpain inhibitor, CP1B, reduces ECM invasion as well as
mRNA expression of MMP-9 and MMP-2 and thus also
the secretion of these proteinases by leukemic (THP-1)
cells independently of their differentiation stages. This is
the first report showing that the calpain/calpastatin
system mediates MMP-mRNA expression of leukemic
(THP-1) cells and as a consequence their invasiveness.
Our evidences extend recent reports suggesting the in-
volvement of calpain activity on the regulation of MMP-2
during SV40 large T-antigen-mediated immortalization of
fibroblasts lacking the gene for the small subunit of cal-
pain (Postovit et al., 2002). How the calpain/calpastatin
system regulates the invasiveness of non-transformed
hematopoietic cells (e.g., monocytes) as well as of cells
with different malignancies remains to be investigated. In
addition, the precise mechanism(s) by which calpain in-
fluences the expression of these MMPs still deserves in-
vestigation. Interestingly, calpain has been reported to be
involved in the ERK/MAPK signaling pathway (Glading
et al., 2000), which is also known to modulate MMP-
9 mRNA expression (Westermarck and Kähäri, 1999). Un-
derstanding the mechanism of MMP regulation by the
calpain/calpastatin system may lead to the development
of novel (antiproteolytic) therapeutic approaches against
leukemic diseases. 
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